Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association.

The sudden death of a competitive athlete is a personal tragedy with great impact on the lay and medical communities.1 Sudden deaths in athletes are usually caused by previously unsuspected cardiovascular disease.2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Such an event often assumes a high public profile because of the generally held perception that trained athletes constitute the healthiest segment of our society. The death of a well-known elite athlete often emphasizes this visibility.1 21 Athletic field catastrophes strike to the core of our sensibilities and often galvanize us. They also inevitably raise a number of practical and ethical issues. This statement is a response to these considerations and represents the consensus of a panel appointed by the American Heart Association Science Advisory and Coordinating Committee. The panel comprised cardiovascular specialists, other physicians with extensive clinical experience with athletes of all ages, and a legal expert. The panel (1) assessed the benefits and limitations of preparticipation screening for early detection of cardiovascular abnormalities in competitive athletes; (2) addressed cost-efficiency and feasibility issues as well as the medical and legal implications of screening; and (3) developed consensus recommendations and guidelines for the most prudent, practical, and effective screening procedures and strategies (the recommendations are listed at the end of this statement). This endeavor seems particularly relevant and timely, given the large number of competitive athletes in this country, recent public health initiatives on physical activity and exercise, and the staging of the 1996 Olympic Games in the United States. The competitive athlete has been described as one who participates in an organized team or individual sport requiring systematic training and regular competition against others while placing a high premium on athletic excellence and achievement.20 The …

[1]  A. Garson,et al.  Arrhythmias and Sudden Cardiac Death in Elite Athletes , 1994, La Pediatria medica e chirurgica : Medical and surgical pediatrics.

[2]  J. Edwards,et al.  Pathologic features of sudden death in children, adolescents, and young adults. , 1985, Chest.

[3]  B. Maron,et al.  Prospective identification by two-dimensional echocardiography of anomalous origin of the left main coronary artery from the right sinus of Valsalva. , 1991, The American journal of cardiology.

[4]  Christine E. Seidman,et al.  α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.

[5]  R. Liberthson,et al.  Sudden death from cardiac causes in children and young adults. , 1996, The New England journal of medicine.

[6]  D. Braden,et al.  Sudden cardiac death in young athletes. A review. , 1991, American journal of diseases of children.

[7]  W Q Sturner,et al.  Incidence of death during jogging in Rhode Island from 1975 through 1980. , 1982, JAMA.

[8]  J. Cantwell,et al.  The role of limited echocardiography in screening athletes. , 1995, The American journal of cardiology.

[9]  B. Waller,et al.  Incorporation of Screening Echocardiography in the Preparticipation Exam , 1995, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[10]  R. Boxer,et al.  EKG screening program for school athletes , 1989, Clinical cardiology.

[11]  B. Maron,et al.  26th Bethesda Conferance: Recommendations for determining eligibility for competetion in athletes with cardiovascular abnormalities , 1994 .

[12]  J. Kark,et al.  Sickle-cell trait as a risk factor for sudden death in physical training. , 1987, The New England journal of medicine.

[13]  K. Stajduhar,et al.  Anomalous origin and course of coronary arteries in adults: identification and improved imaging utilizing transesophageal echocardiography. , 1991, American heart journal.

[14]  B. Maron,et al.  Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.

[15]  B. Maron,et al.  Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. , 1995, Circulation.

[16]  B. Maron,et al.  Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. , 1995, The American journal of cardiology.

[17]  W. Roberts,et al.  Causes of sudden death in competitive athletes. , 1986, Journal of the American College of Cardiology.

[18]  T. Meinertz,et al.  ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. , 1990, American heart journal.

[19]  W. Roberts,et al.  Sudden death while running in conditioned runners aged 40 years or over. , 1980, The American journal of cardiology.

[20]  R. Feinstein,et al.  Echocardiographic Screening as Part of a Preparticipation Examination , 1993 .

[21]  R. Bonow,et al.  Hypertrophic cardiomyopathy. , 1987, Disease-a-month : DM.

[22]  B. Maron,et al.  Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease. , 1987, Journal of the American College of Cardiology.

[23]  P. Thompson,et al.  Death during jogging or running. A study of 18 cases. , 1979, JAMA.

[24]  N. Smith.  Sports medicine : health care for young athletes , 1983 .

[25]  A. Moss,et al.  The Long QT Syndrome: Prospective Longitudinal Study of 328 Families , 1991, Circulation.

[26]  P. Thompson,et al.  Acute cardiac events temporally related to cocaine abuse. , 1986, The New England journal of medicine.

[27]  D. Corrado,et al.  Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.

[28]  W. Rodney,et al.  The athletic heart syndrome. , 1985, The New England journal of medicine.

[29]  G. Diamond,et al.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. , 1979, The New England journal of medicine.

[30]  B. Maron,et al.  Surviving competitive athletics with hypertrophic cardiomyopathy. , 1994, The American journal of cardiology.

[31]  B. Maron,et al.  Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. , 1986, The New England journal of medicine.

[32]  R. Longo,et al.  Magnetic resonance imaging in right ventricular dysplasia. , 1992, The American journal of cardiology.

[33]  B. Maron,et al.  Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. , 1983, The American journal of cardiology.

[34]  B. Maron,et al.  Risk for sudden cardiac death associated with marathon running. , 1996, Journal of the American College of Cardiology.

[35]  Tsung Sh,et al.  Sudden death in young athletes. , 1982, Archives of pathology & laboratory medicine.

[36]  M. Mitten.  Team Physicians and Competitive Athletes: Allocating Legal Responsibility for Athletic Injuries , 1993 .

[37]  D. Corrado,et al.  Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. , 1990, The American journal of medicine.

[38]  J E Smialek,et al.  Sports-related and non-sports-related sudden cardiac death in young adults. , 1991, American heart journal.

[39]  F O Mueller,et al.  Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.

[40]  R. Virmani,et al.  Cardiovascular effects of cocaine: an autopsy study of 40 patients. , 1988, American heart journal.

[41]  G. Thiene,et al.  VENTRICULAR ARRHYTHMIAS AND SUDDEN DEATH IN ATHLETES , 1984, Annals of the New York Academy of Sciences.

[42]  B. Maron.  Structural features of the athlete heart as defined by echocardiography. , 1986, Journal of the American College of Cardiology.

[43]  W. Williams,et al.  Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. , 1985, Progress in cardiovascular diseases.

[44]  C. W. Linder,et al.  The preparticipation examination of athletes. Comparison of single and multiple examiners. , 1985, American journal of diseases of children.

[45]  A. Nava,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[46]  R. Cantu,et al.  Nontraumatic sports death in high school and college athletes. , 1995, Medicine and science in sports and exercise.

[47]  W. Edwards,et al.  Sudden unexpected death in children and adolescents. , 1985, Journal of the American College of Cardiology.

[48]  M. Proschan,et al.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. , 1991, The New England journal of medicine.

[49]  B. Maron,et al.  Ethical, legal and practical considerations affecting medical decision-making in competitive athletes. , 1994, Journal of the American College of Cardiology.

[50]  B. Maron.  Sudden death in young athletes. Lessons from the Hank Gathers affair. , 1993, The New England journal of medicine.

[51]  M. Cheitlin,et al.  Sudden Death as a Complication of Anomalous Left Coronary Origin From the Anterior Sinus of Valsalva: A Not‐So‐Minor Congenital Anomaly , 1974, Circulation.

[52]  B. Maron,et al.  Preparticipation echocardiographic screening for cardiovascular disease in a large, predominantly black population of collegiate athletes. , 1989, The American journal of cardiology.

[53]  F O Mueller,et al.  Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. , 1995, The New England journal of medicine.

[54]  B. Maron,et al.  Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse , 1994 .

[55]  B. Maron,et al.  Sudden death and the competitive athlete: perspectives on preparticipation screening studies. , 1986, Journal of the American College of Cardiology.

[56]  J. Mitchell,et al.  Revised eligibility recommendations for competitive athletes with cardiovascular abnormalities. , 1994, Journal of the American College of Cardiology.

[57]  E. Fisman,et al.  Sudden unexpected death in persons <40 years of age , 1991 .

[58]  R. Virmani,et al.  Nontraumatic death in joggers. A series of 30 patients at autopsy. , 1982, The American journal of medicine.

[59]  J. Seidman,et al.  Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[60]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[61]  N. Kaplan,et al.  Task force 4: Systemic hypertension , 1994 .

[62]  J. Seidman,et al.  A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.

[63]  M. Leppert,et al.  The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. , 1992, The New England journal of medicine.

[64]  B. Maron,et al.  Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes. , 1996, JAMA.